Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abbott Laboratories

137.71
+0.13000.09%
Pre-market: 137.24-0.4700-0.34%05:49 EST
Volume:8.16M
Turnover:1.12B
Market Cap:238.83B
PE:18.02
High:138.50
Open:136.90
Low:136.04
Close:137.58
Loading ...

Company Profile

Company Name:
Abbott Laboratories
Exchange:
NYSE
Establishment Date:
1888
Employees:
114000
Office Location:
100 Abbott Park Road,Abbott Park,North Chicago,Illinois,United States
Zip Code:
60064-6400
Fax:
- -
Introduction:
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois.

Directors

Name
Position
Robert Ford
Chairman of the Board and Chief Executive Officer and Director
Claire Babineaux Fontenot
Director
Daniel J. Starks
Director
Darren W. McDew
Director
John G. Stratton
Director
Michael F. Roman
Director
Michael G. O'Grady
Director
Michelle A. Kumbier
Director
Nancy McKinstry
Director
Paola Gonzalez
Director
Sally E. Blount
Director

Shareholders

Name
Position
Robert Ford
Chairman of the Board and Chief Executive Officer and Director
Philip P. Boudreau
Executive Vice President, Finance and Chief Financial Officer
Andrea Wainer
Executive Vice President, Rapid and Molecular Diagnostics
Daniel Salvadori
Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products
Hubert L. Allen
Executive Vice President, General Counsel and Secretary
John A. McCoy, Jr.
Vice President, Finance and Controller
Lisa D. Earnhardt
Executive Vice President and Group President, Medical Devices
Louis H. Morrone
Executive Vice President, Core Diagnostics
Mary K. Moreland
Executive Vice President, Human Resources